Several mentions of "strategies" in the annual report.
e.g. page 28, under the heading of "Strategy, Future Developments and Prospects"
"Starpharma aims to create value for its shareholders through the clinical and commercial development of its proprietary products"
Is SPL any good at formulating strategies?
e.g. page 33, under the heading of "Remuneration strategy"
"Starpharma aims to ensure that its remuneration strategy aligns the interests of its executives and employees with those of its shareholders." (sic)
Cash held is now approx ten cents per share. SP down to fourteen cents today. If the SP falls much further then SPL's cash will soon be more than its market cap. Which for most stocks would make it safe to hold.
Several mentions of "strategies" in the annual report.e.g. page...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $2.84K | 27.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39360 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 115551 | 4 |
View Market Depth
| Last trade - 12.58pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |